Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating…
FDA approves Lilly’s EBGLYSSยฎ for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that Chinaโs National Medical Products Administration (NMPA) has…
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory to Expand BCG Supply in the United States
ImmunityBio has signed an exclusive U.S. development and supply agreement with Japan…
First locally discovered drug candidate: UAE joins AI-powered drug development race
The UAE has announced its first fully AI-discovered drug candidate, ISM0387, developed…
UK Biotech Day 2026 to Spotlight Innovation, Investment and Collaboration in London
UK Biotech Day 2026 will bring together leaders in industry, research, government,…
GSK completes acquisition of 35Pharma Inc.
GSK plc has completed the acquisition of 35Pharma Inc., adding HS235, a…
Regeneron and Telix Announce Strategic Radiopharma Collaboration
Regeneron and Telix Pharmaceuticals announce a strategic collaboration to develop next-generation radiopharmaceutical…
NYU Abu Dhabi Develops Smart MRI Molecules That Detect and Treat Cancer Simultaneously
NYU Abu Dhabi researchers develop smart MRI molecules that can simultaneously detect…
Bayerโs Kerendia Gains EU Approval for Expanded Use in Heart Failure Treatment
Bayer receives European Commission approval to expand the use of Kerendia (finerenone)…
